|
G.A. Ignatenko, A.E. Bagriy, A.V. Prikolota, O.A. Prikolota, E.S. Mikhailichenko, I.A. Golodnikov, O.N. Bagriy
Experience with the use of valsartan/sacubitril in patients with chronic heart failure in combination with type 2 diabetes mellitus and paroxysmal atrial fibrillation
|
№12 / 2023
|
|
O.N. Kurochkina, A.V. Baranov, A.S. Sazhina, A.N. Bogomolov
Modern methods of treatment of elderly patients with chronic heart failure: a literature review
|
№1-2 / 2023
|
|
D.A. Sychev, O.D. Ostroumova, A.P. Pereverzev, A.I. Kochetkov, M.V. Klepikova, E.Yu. Ebzeeva, V.A. De
Risk factors of drug-induced diseases. Part 2. Comorbid diseases and lifestyle factors
|
№12 / 2021
|
|
O.D. Ostroumova (1, 2), A.I. Kochetkov (1), S.V. Batyukina (1), N.L. Lyakhova (3)
Approaches to choosing a direct oral anticoagulant in the treatment of polymorbid patients with atrial fibrillation
|
№3 / 2020
|
|
V.A. Sergeeva (1), S.P. Eliseeva (2), E.V. Zhuravleva (1)
PERIPARTUM CARDIOMYOPATHY: 10-YEAR CLINICAL FOLLOW-UP
|
№6 / 2018
|
|
P.A. Lebedev (1), A.F. Verbovoy (1), K.A. Mateesku (1), M.Yu. Aleksandrov (2), R.A. Povalayeva (3)
LEFT VENTRICLE DYSFUNCTION AND ITS DETERMINANTS IN PATIENTS WITH ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION
|
№18 / 2017
|
|
M.E. Statsenko, S.V. Turkina, I.A. Tyshchenko, S.V. Fabritskaya, L.V. Poletaeva
POTENTIALS FOR THE DRUG CORRECTION OF SECONDARY MITOCHONDRIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND COMORBID PATHOLOGY
|
№6 / 2017
|
|
M.Yu. Ogarkov (1), Yu. V. Kovaleva (1), T.A. Mulerova (2)
BISOPROLOL IN THE TREATMENT OF CHRONIC HEART FAILURE
|
№13 / 2016
|
|
S.A. Abduragimov (1), N.V. Teplovа (1), N.A. Volov (1), S.L. Sofrina (2), M.A. Benevskaya (1)
TAURINE IN THE COMPLEX TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION
|
№13 / 2016
|
|
A.S. Adamchik, D.I. Panchenko
INCREASED THYROID-STIMULATING HORMONE LEVEL AS A MARKER OF PROGRESSION OF HEART FAILURE IN CARDIAC PATIENTS
|
№5 / 2016
|
|
S.V. Shalaev (1, 2), L.V. Kremneva (3), O.V. Abaturova (1)
NEBIVOLOL IN THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE
|
№13 / 2015
|
|
A.I. Chesnikova (1), E.S. Godunko (1, 2), A.V. Khripun (1, 2), V.P. Terentev (1)
FEATURES OF LEFT VENTRICULAR REMODELING AND THE DEVELOPMENT OF CHRONIC HEART FAILURE IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION, TAKING INTO ACCOUNT THE MODE OF REVASCULARIZATION AND ADHERENCE TO THERAPY
|
№13 / 2015
|
Русский
